Who
1,600 people with Parkinson’s, who:
• were diagnosed with Parkinson’s at age 30 or over
• have been taking dopamine medication to treat Parkinson’s for at least the past 2 months before starting the trial
You won’t be able to take part if you have:
• certain Parkinson’s gene mutations (PRKN, PINK1, DJ1)
• significantly low blood pressure (checked by the research team)
• had advanced Parkinson’s treatments (e.g. DBS), or a diagnosis of dementia
• or you are breastfeeding, pregnant, or plan to become pregnant while part of the trial
Where
Glasgow, Edinburgh, Dundee, Bangor, Cardiff, Wrexham, Belfast, Taunton, Yeovil, Bath, Poole, Christchurch, Exeter, Plymouth, Chertsey, Oxford, Ashford, Southampton, Brighton, Coventry, Birmingham, Shrewsbury, Scarborough, Sheffield, Leeds, Salford, Liverpool, Gateshead, North Shields, Newcastle upon Tyne, Central London, East London - Homerton, East London - Whitechapel, West London, Southeast London - Denmark Hill, Southeast London - Lewisham, Southwest London, Ipswich, Norwich, Cambridge, Romford